TY  - GEN
AU  - Engert,A
TI  - Treatment of lymphocyte-predominant Hodgkin lymphoma
SN  - 1569-8041
PY  - 2008///0730
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bleomycin
KW  - Combined Modality Therapy
KW  - Dacarbazine
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Hodgkin Disease
KW  - classification
KW  - Humans
KW  - Lymphocytes
KW  - pathology
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Radiotherapy
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Vinblastine
N1  - Publication Type: Comparative Study; Journal Article; Review
UR  - https://doi.org/10.1093/annonc/mdn194
ER  -